Introduction
Retinopathy of prematurity, often called ROP, is an eye disease that can affect some premature babies. It happens when the blood vessels in the retina, the light-sensitive tissue at the back of the eye, do not develop in the usual way. This FAQ explains what ROP is, why it happens, how it is found, how it is treated, and what families should know about long-term outlook and prevention.
Common Questions About Retinopathy of prematurity
What is retinopathy of prematurity? Retinopathy of prematurity is a disorder of retinal blood vessel development in babies born too early. In a full-term pregnancy, the retina receives a carefully timed supply of blood vessels before birth. When a baby is born early, that process is interrupted. The vessels may stop growing normally, then later grow in an abnormal and fragile pattern. In severe cases, this can lead to scarring, retinal detachment, and vision loss.
What causes it? The main cause is premature birth, especially when a baby is born very early and has a very low birth weight. After birth, the retina is exposed to a different oxygen environment than it would have had in the womb. This shift can disturb the signals that control blood vessel growth. In the first phase, vessel growth may slow or stop. Later, the retina may respond by releasing growth signals that cause abnormal vessel proliferation. This two-phase process is central to ROP.
ROP is not caused by poor parenting, feeding choices, or ordinary contact with the baby. It is linked to the biology of premature birth and the medical conditions that often come with it, such as needing oxygen support, having unstable breathing, or being very ill in the newborn period.
What symptoms does it produce? Early ROP usually does not cause noticeable symptoms. Most babies with ROP look completely normal to parents at first. That is one reason screening is so important. If the disease becomes severe and affects vision later, a child may show signs such as poor visual tracking, abnormal eye movements, crossing of the eyes, or reduced ability to fixate on objects. However, these signs are not reliable early warning markers, and many infants with treatable ROP have no visible symptoms before an eye exam.
Questions About Diagnosis
How is ROP found? ROP is diagnosed by an eye examination performed by an ophthalmologist who is experienced in examining premature infants. The doctor uses dilating drops to widen the pupils and a special light and lens system to look at the retina. The goal is to determine how far blood vessel development has progressed and whether any abnormal vessel growth is present.
When are babies screened? Screening usually begins based on the baby’s gestational age, birth weight, and overall medical condition. Babies who are born very early or have very low birth weight are typically examined at a specific postnatal age, often around 4 to 9 weeks after birth, depending on clinical guidelines and the baby’s maturity. The schedule is designed so doctors can detect disease before it reaches a dangerous stage.
Why is screening repeated? ROP can change quickly. A baby may have a mild exam one week and a more advanced stage the next. Repeated exams allow clinicians to track retinal vascular development and identify signs that treatment is needed. Screening may continue until the retina is fully vascularized or the disease has clearly stabilized.
What do doctors look for during diagnosis? Ophthalmologists assess the zone of the retina involved, the stage of abnormal vessel growth, and whether the disease is worsening. They also look for “plus disease,” which means the retinal blood vessels are unusually twisted and enlarged. This suggests active disease and a higher risk of progression. These findings help determine whether the ROP is mild, moderate, or severe.
Questions About Treatment
Does every baby with ROP need treatment? No. Many babies have mild ROP that improves without any procedure. Treatment is reserved for disease that is likely to threaten vision, especially when abnormal vessel growth or scarring is progressing. The decision is based on the stage and location of disease, not simply on the diagnosis itself.
What are the main treatments? The most established treatment is laser therapy, which destroys the peripheral areas of the retina that are not receiving enough normal blood supply. This reduces the retina’s drive to produce abnormal vessels. In some cases, anti-vascular endothelial growth factor, or anti-VEGF, injections may be used to block the signal that stimulates abnormal vessel growth. These treatments are chosen based on the type and severity of ROP and the baby’s overall situation.
How does laser treatment work? Laser treatment targets the outer retinal areas that would otherwise signal the body to form fragile new vessels. By reducing that signal, laser can stop the disease from worsening. It is often effective, though it may slightly reduce peripheral vision later in life because it treats retina that would not have developed normal vessel growth anyway.
How do anti-VEGF injections work? Anti-VEGF medicines reduce the activity of vascular endothelial growth factor, a protein that drives abnormal vessel growth in ROP. These injections can be useful in certain cases, especially when disease is in a pattern known to respond well or when laser is difficult. Because the medication can remain active in the body for some time, babies treated this way need careful follow-up to ensure the retina continues to develop normally and the disease does not recur.
Is surgery ever needed? Yes, but usually only in advanced cases. If ROP leads to retinal detachment, surgery may be required to try to reattach the retina and preserve vision. Surgical outcomes depend on how advanced the disease is and how quickly it is treated. Preventing progression before this stage is much better than treating advanced detachment.
Questions About Long-Term Outlook
Does ROP go away on its own? Mild ROP often regresses without treatment as the retina finishes developing. This is common in babies whose disease never reaches a severe stage. Even when ROP improves, doctors continue to monitor the eyes because some babies remain at risk for later visual problems.
Can ROP cause permanent vision loss? Yes, severe ROP can cause lasting damage if it leads to scarring, pulling on the retina, or detachment. Even babies who are treated successfully may still have a higher chance of needing glasses, developing nearsightedness, or having problems such as strabismus or amblyopia. Early detection and treatment greatly improve the odds of preserving useful vision.
What is the outlook for children who had ROP? Many children with treated or mild ROP do well, especially when follow-up eye care continues through infancy and childhood. Some will need ongoing vision monitoring because premature birth itself can affect visual development. Long-term care may include checks for refraction problems, eye alignment issues, and retinal changes that can appear later.
Can problems appear later in life? They can. Even if the retina stabilizes in infancy, people who had ROP may have an increased risk of nearsightedness, cataracts, glaucoma, retinal tears, or late-onset retinal detachment. Not every child develops these complications, but lifetime awareness of the history of ROP is important for future eye exams.
Questions About Prevention or Risk
Can ROP be prevented? The most effective way to reduce risk is preventing premature birth when possible, but that is not always controllable. In newborn care, careful oxygen management, good overall medical support, and timely screening help reduce the chance of severe ROP. Because the condition is tied to retinal development, prevention is mostly about lowering the risk of progression rather than eliminating all risk.
Who is at highest risk? Babies born very early, especially those with very low birth weight, are at the highest risk. The earlier the birth, the more immature the retinal blood vessels are at delivery. Other factors that can increase risk include prolonged oxygen therapy, respiratory instability, infection, anemia, or other serious illness in the newborn period. A baby’s specific risk depends on a combination of these factors.
Does oxygen cause ROP? Oxygen itself does not directly cause ROP in the simple sense, but fluctuations in oxygen levels can influence how retinal blood vessels grow. Very premature babies are medically fragile and may need oxygen to survive. The key is careful monitoring so oxygen is used appropriately, avoiding both too little and too much. Modern neonatal care aims to balance those needs closely.
Can breastfeeding or formula prevent it? Feeding choice alone does not prevent ROP. Good nutrition supports overall growth and health, which is important for premature babies, but it is not a substitute for eye screening or medical management. Families should focus on the treatment plan and follow-up schedule recommended by the neonatal and eye care teams.
Less Common Questions
Is ROP the same as blindness in premature babies? No. Many premature babies never develop ROP, and many who do have mild disease that resolves. ROP is one possible cause of vision problems in premature infants, but it is not inevitable and it is not the same as blindness. Severe untreated ROP can cause blindness, which is why screening matters.
Can both eyes be affected? Yes, ROP usually affects both eyes, though not always to the same degree. That is why both eyes are examined during screening and treatment planning. The severity can differ slightly from one eye to the other.
Will treatment hurt the baby? The treatment process may be uncomfortable, and the medical team uses methods to reduce pain and stress as much as possible. Babies are closely monitored during and after treatment. The potential benefit of preventing serious vision loss outweighs the temporary discomfort associated with treatment.
Should parents watch for changes after discharge? Yes. Parents should keep every scheduled eye appointment and mention any concerns about eye alignment, poor visual response, or unusual movements. Follow-up is especially important because some babies need repeated exams even after leaving the hospital. Missing visits can allow recurrent or delayed disease to go unnoticed.
Conclusion
Retinopathy of prematurity is a disease of abnormal retinal blood vessel development in premature babies. It often has no early symptoms, which makes screening essential. Most mild cases improve without intervention, but more advanced disease can threaten vision and may require laser treatment, anti-VEGF therapy, or surgery. The best outcomes come from early identification, careful follow-up, and prompt treatment when needed. Families of premature infants should understand that ROP is manageable in many cases, but only when it is monitored closely and taken seriously from the start.